Survey of COVID-19 Infection

Completed

• Conditions: COVID-19; Infections

• Registration Number: NCT05706064
• Lead Sponsor: Xijing Hospital

Brief Summary

Using online questionnaires, we will obtain data regarding COVID-19 infection and treatment, including incidence rate, hospitalization rate, severity of the infection, medications, mortality rate, etc, in both hospital and communities after the change of disease control policy in China.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-12-28
• Study First Submitted: 2023-01-29
• Study First Submitted QC: 2023-01-29
• Study First Posted: 2023-01-31
• Primary Completion: 2023-04-30
• Study Completion: 2023-06-30
• Status Verified: 2024-01
• Last Update Submitted: 2024-01-22
• Last Update Posted: 2024-01-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200000

Inclusion Criteria

• N/A

Exclusion Criteria

• N/A

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
All-cause mortality	6 months	Quickly obtain the all-cause mortality in patients with COVID-19

Secondary Outcome Measures

Name	Time	Method
Medication for COVID-19 treatment	6 months	Any medication for COVID-19 treatment
Hospitalization rate due to COVID-19 infection	6 months	Hospitalization rate due to COVID-19 infection
Severity of COVID-19 infection	6 months	severity of the COVID-19 infection
Incidence rate of COVID-19 infection	6 months	Incidence rate of COVID-19 infection

Trial Locations

Locations (1)

Ling Tao; 🇨🇳 Xi'an, Shannxi, China